Brought to you by 
CNS and respiratory start-up Cerecor completes $22.5mm Series A round
01 May 2012
Executive Summary
Cerecor Inc. (drug candidates that act primarily in the brain) has completed a $22.5mm Series A financing. Maxim Group was the placement agent. According to the Form D filing, 156 investors participated, including company board members. The initial offering amount for the round was $15mm, but back in May 2011 Cerecor was targeting $30mm.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CNS and respiratory start-up Cerecor completes $22.5mm Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice